Invivyd Secures $125M Financing to Accelerate Antiviral Pipeline
Dateline Introduction Waltham, Massachusetts — November 18, 2025 — Invivyd, a biotechnology company focused on developing innovative antiviral therapeutics,...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Dateline Introduction Waltham, Massachusetts — November 18, 2025 — Invivyd, a biotechnology company focused on developing innovative antiviral therapeutics,...
Dateline Introduction Austin, Texas — November 18, 2025 — Alafair Biosciences, Inc., a medical-device company specializing in advanced biopolymer...
